Aclaris Therapeutics, Inc. (ACRS)

Typically moves ±3.84% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Across 22 earnings reports since May 07, 2021, Aclaris Therapeutics, Inc. (ACRS) has a clear post-earnings pattern. It moves ±3.84% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +5.22% (Feb 24, 2022) and its largest decline was -10.87% (Nov 02, 2021). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How ACRS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.84%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☀ PRE	-4.1%	open_in_new
May 07, 2026	☀ PRE	+1.99%	open_in_new
Feb 26, 2026	☀ PRE	-5.44%	open_in_new
Nov 06, 2025	☀ PRE	+0.44%	open_in_new
Aug 07, 2025	☀ PRE	+1.29%	open_in_new
May 08, 2025	☀ PRE	+4.8%	open_in_new
Feb 27, 2025	☀ PRE	-7.14%	open_in_new
Nov 06, 2024	☀ PRE	+1.8%	open_in_new
Aug 07, 2024	☀ PRE	-2.46%	open_in_new
May 07, 2024	☽ POST	-8.96%	open_in_new
Feb 27, 2024	☀ PRE	-0.83%	open_in_new
Nov 06, 2023	☀ PRE	+2.05%	open_in_new
Aug 07, 2023	☀ PRE	-7.21%	open_in_new
May 08, 2023	☀ PRE	-6.46%	open_in_new
Feb 23, 2023	☀ PRE	+0.63%	open_in_new
Nov 08, 2022	☀ PRE	+4.31%	open_in_new
Aug 03, 2022	☀ PRE	+1.41%	open_in_new
May 10, 2022	☀ PRE	-0.27%	open_in_new
Feb 24, 2022	☀ PRE	+5.22%	open_in_new
Nov 02, 2021	☀ PRE	-10.87%	open_in_new
Aug 05, 2021	☀ PRE	+3.14%	open_in_new
May 07, 2021	☀ PRE	-3.69%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.84%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 22 →

Funds holding

$90642401

Total value held

Buying

18 added · 4 reduced

Blackrock, Inc.

$53095772 +35.51%

State Street Corp

$17220749 +62.06%

Northern Trust Corp

$5283456 +37.15%

Goldman Sachs Group Inc

$3222447 +3.48%

Jpmorgan Chase & Co

$2354200 -3.63%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
S-3ASR	20260806	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov

Frequently asked about ACRS earnings

When does Aclaris Therapeutics, Inc. report earnings next? expand_more

Aclaris Therapeutics, Inc. (ACRS)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ACRS stock move after earnings? expand_more

Over 22 reports, ACRS has moved an average of ±3.84% the session after earnings, closing higher 50.0% of the time.

What was ACRS's biggest post-earnings move? expand_more

ACRS's largest post-earnings gain on record was +5.22% on Feb 24, 2022, and its largest decline was -10.87% on Nov 02, 2021.

Where can I find Aclaris Therapeutics, Inc.'s SEC filings? expand_more

All of Aclaris Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.